Download link:
.
.
==>
.
Malignant Brain Tumors: State-of-the-Art Treatment, ISBN-13: 978-3319498638
.
<==
.
.
"Malignant Brain Tumors: State-of-the-Art Treatment" provides a comprehensive overview of the latest advancements in the diagnosis and management of malignant brain tumors. The book discusses a range of treatment modalities including surgical techniques, radiation therapy, and innovative pharmacological approaches, highlighting the importance of a multidisciplinary approach to improve patient outcomes. It integrates cutting-edge research, clinical practices, and future perspectives in neurooncology, making it a valuable resource for healthcare professionals involved in the care of patients with these challenging conditions.
.
Title: Malignant Brain Tumors: State-of-the-Art Treatment
ISBN-13: 978-3319498638
Publisher: Springer
Publication Year: 2016
Editors: Andrew S. McCormick, Takuya K. Makino, and Ranjit S. K. R. S. Balakrishnan
Format: Hardcover
Pages: 412
Language: English
Description: This book provides comprehensive coverage of the latest advancements in the treatment of malignant brain tumors, including surgical techniques, radiation therapy, and innovative pharmacological approaches. It serves as a valuable resource for clinicians, researchers, and healthcare professionals involved in neuro-oncology.
.
"Malignant Brain Tumors: State-of-the-Art Treatment" serves as a comprehensive resource that encapsulates the latest advancements in the diagnosis and management of malignant brain tumors. The book highlights innovative therapeutic strategies, multidisciplinary approaches, and emerging research, offering insights from leading experts in the field. It addresses vital topics such as surgical techniques, radiation therapy, chemotherapy, and the role of immunotherapy, ensuring that healthcare professionals are equipped with the most current knowledge to improve patient outcomes. By bridging the gap between clinical practice and cutting-edge research, this work is invaluable for oncologists, neurosurgeons, and researchers dedicated to combating malignant brain tumors.
.
